Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Animal Biotechnology Market Size, Share, Growth, Research: Product Type: Reproductive and Genetic Products, Diagnostic Tests, Drugs, Vaccines; By Application: Food Safety and Drug Development, Development of Animal Pharmaceuticals; Regional Analysis; Competitive Landscape; Industry Events and Developments; 2022-2027

Global Animal Biotechnology Market Outlook

The global animal biotechnology market size reached a value of about USD 24.24 billion in 2021. The market is growing at a rapid rate and is likely to register a CAGR of about 7.0% in the forecast period of 2022-2027. The market is likely to attain a value of 36.37 billion by 2027.

 

News and Developments in the Market for Animal Biotechnology

In March 2022, following a safety inspection, FDA declared its first low-risk decision for the advertising of products from genome-edited beef cattle and their offspring. This examination is used as a case study in Centre Veterinary Medicine CVM's webinar to show how the agency concluded that the Intentional Genomic Alterations (IGA) did not raise any safety concerns.

 

Later, FDA’s Centre for Veterinary Medicine released a pre-recorded webinar to inform about the low-risk inspection process and animals that can pose a low risk for genome alterations.  This has added to the growing animal biotechnology market demand.

 

In October 2021, the members of the House Agriculture Committee had urged both organisations, the United States Department of Agriculture (USDA) and the Food and Drug Administration (FDA) to call for an efficient, modernised, and science-based animal biotechnology regulatory system to implement innovations in the market on time.

 

The current regulatory system is slow in releasing creations, and so, officials are requesting for the management to be handed over to USDA from FDA’s control.  Such initiatives have been boosting the animal biotechnology market growth.

 

In October 2021, the Department of Biotechnology launched the ‘One Health’ program. This program aims to detect Zoonotic infections and transboundary diseases all over India. This program was driven by the adverse effects of the COVID-19 pandemic, as it showed that the risk of infectious organisms crossing the species boundary is rising.

 

In January 2021, a boar semen life extender formula was given a patent. The formula was developed to improve the post-thaw fertility and conception rate to develop cryopreservation facilities for the semen. This will help in increasing productivity, benefiting the pig farmers, animal husbandry departments, and researchers.

 

Rising Support from the Governments, Increasing Vaccine Development, and Thriving Population to Drive the Animal Biotechnology Market

Animal biotechnology refers to a branch of biotechnology in which with the utilisation of molecular biology techniques, animals are altered genetically. The aim is to produce genetically modified animals with improved growth rates and increased disease resistance. It improves the production and their usefulness for different fields such as agriculture, industrial, and pharmaceutical. This is done using various technologies such as artificial intelligence (AI), Embryo Transfer (ET), and In-Vitro Fertilisation (IVF), among others.

 

  • The increasing number of initiatives taken by the government to promote animal healthcare, funding to improve health infrastructure, and collaborations with other governments to acquire better technology can increase the animal biotechnology market share.
  • The rising development of vaccines due to the rapid spread of animal diseases has been adding to the demand for biotechnology. These diseases can easily spread to humans via contaminated water, food, or direct contact with an infected being. Vaccines are a great preventive measure for these diseases, which can significantly help the market growth.
  • The growing population around the world increases the demand for products, leading to increased productivity in the livestock industry. This can be achieved through various methods like genome alteration with better genes, embryo transplant, etc., which will further aid the market demand for animal biotechnology.

 

Enhanced Productivity in Livestock Animals, Rising Education, Technologic Advancement, and the Thriving Population Likely to Provide Significant Growth Opportunities in the Animal Biotechnology Market

Enhanced Productivity in Livestock Animals

The animals can be enhanced with genome alteration and insemination to increase the production rate while improving the quality suited for humans, which is likely to lead the market growth.

 

Increasing Education in Animal Biotechnology

Several initiatives to increase programmes related to animal biotechnology in universities can propel the market development, and more research will help in developing better procedures which can be adopted by veterinaries.

 

Technological Advancement Improving Animal Biotechnology

The increasing technological developments have made it possible to carry out more complicated procedures. With the increased computing power helping to improve the processes, and implementation of the latest techniques like genomic sequencing, cloning, and direct gene insertion is expected to propel the animal biotechnology market development.

 

Growing Population Around the World

With the population around the world constantly growing, it simultaneously increases the demand for animal products which would, in turn, increase the adoption of livestock animals. This is a scenario especially strong in the Asia Pacific, with emerging countries like India and China having large populations, providing excellent opportunities for market expansion.

 

Ethical Restraints, Adverse Effects on Humans, and Strict Regulations to Pose as Challenges in the Animal Biotechnology Market

  • Ethical Restraints for Animal Biotechnology -There have been several controversies about animal biotechnologies. The use of invasive procedures and genetically modified animals may have abnormalities.
  • Effects on Humans by Food from Modified Animals- The adverse effects of foods produced by cloned or genetically modified animals on humans have been a frequently recurring topic.
  • Regulations for Proper Procedures to Ensure Safety- There are strict guidelines to ensure safe and non-invasive methods are implemented as the cloned or modified animal may have abnormalities and result in undesirable consequences. These guidelines may hinder the speed and development of the market.

 

Animal Biotechnology Market Analysis

The market can be segmented based on product type into reproductive and genetic products, diagnostic tests, drugs, and vaccines. Based on the applications can be divided into food safety and drug development, and the development of animal pharmaceuticals, among others.

 

The regional markets can be divided into North America, Latin America, the Middle East and Africa, Europe, the Asia Pacific; among them, the Asia Pacific shows significant growth potential. The extensive EMR report, curated by expert researchers, provides detailed insights on the market based on Porter's five forces model along with giving a SWOT analysis.

 

The market report gives a comprehensive analysis of the following key players in the global animal biotechnology market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

 

  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Virbac Group
  • Santa Cruz Biotechnology, Inc.
  • Others

 

Reproductive and Genetic Products, Diagnostic Tests, Drugs, and Vaccines are the Major Product Types in Animal Biotechnology Market

The growing population and demand for products have increased the adoption of animals, providing significant opportunities for the growth of the industries across all segments. The reproductive and genetic products segment has a lot of future growth possibilities as the adoption of livestock animals increases. It can include AI insemination of better breeds in lower breed cattle.

 

The vaccines segment is the most positively affected by the Covid 19 pandemic, leading to the increased focus on early diagnosis for abnormalities and increased vaccination adoption to develop resistance. Thus, increasing the growth of healthy animals, which will bolster the animal biotechnology market development.

 

The diagnostic tests segment has been multiplying, owing to the COVID 19 pandemic, to help detect and diagnose any medical condition faster and give an in-depth analysis. The drug segment develops with the diagnostic segment, as with a faster and more in-depth diagnosis of diseases, the medicines for it can be developed and administered more effectively.

 

Animal Biotechnology to Find Wide Applications in Food Safety and Drug Development, Development of Animal Pharmaceuticals

According to the animal biotechnology market research, the utilisation of animal biotechnology is constantly rising with the surging demand for animal products. The Food Safety and Drug Development segment has been implementing biotechnology to modify the animals so they can produce therapeutic proteins for the products, which helps the development of the segment.

 

For a long time, animals have been for the development of drugs for humans by testing them on animals to ensure safety and efficiency, leading to the growth of the development of the animal pharmaceuticals segment.

 

Asia Pacific and North America to Have a Strong Hold on the Global Animal Biotechnology Market

The Asia Pacific region is expected to show the highest growth rate in the market for animal biotechnology attributed to the high density of population and cattle adoption to meet the increasing demand. The emerging economies are also shifting toward biotechnology services such as genetic modifications and advanced diagnosis for early detection of abnormalities. This can help in the production of therapeutic products and medicines to counter diseases.

 

The major players and government organisations are making initiatives to develop biotechnology services, keeping animal welfare in mind. The animal biotechnology market drivers include technological advancements and innovations in countries such as China, Japan, and South Korea are increasing the animal biotechnology adoption.

 

North America holds the largest market share in animal biotechnology as the adoption of pet animals keeps rising, and the prevalence of diseases such as zoonosis keeps growing. The region has adopted advanced technologies for animal healthcare at an early stage. The government and private companies are taking initiatives to research and develop better procedures, which is likely to enhance the animal biotechnology market share for the region.

 

Competitive Landscape of Animal Biotechnology

Bayer AG: Bayer AG is a life science company innovating in the areas of healthcare and agriculture. It is one of the key market players in the animal biotechnology market. They frequently conduct animal studies with proper care and maintaining safety measures, they obtain their research animals through authorized breeders.

 

Bayer AG research on the latest scientific findings in animal husbandry and welfare. The research is conducted mainly on a small number of transgenic mice that are bred at Bayer.

 

Boehringer Ingelheim International GmbH: Boehringer Ingelheim is a leading company in the animal health industry, working with professionals on the latest innovation for the diagnosis of diseases to protect and prevent the animals from diseases. The company works for both companion animals and livestock. They have created many ground-breaking solutions by collaborating with private research companies to treat infections.

 

They work on human and animal diseases providing products for chronic disorders in humans, and Inhaler for asthma, stem cells to treat moderate joint inflammations in horses, and many more for multiple animals.

 

Zoetis Inc. is a leading key player in the animal biotechnology market. It is one of the world’s leading animal healthcare companies, driven by a goal to improve the world for animals. They provide medicines, vaccines, and diagnostic services to over 100 countries.

 

The primary work by the company includes detecting, diagnosing, and developing vaccines and medications for companion and livestock animals. Their products range from antiparasitic solutions to treat lice infestation to pet diabetes monitoring systems.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Application
  • Region
Breakup by Product Type
  • Reproductive and Genetic Products
  • Diagnostic Tests
  • Drugs
  • Vaccines
Breakup by Application
  • Food Safety and Drug Development
  • Development of Animal Pharmaceuticals
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Virbac Group
  • Santa Cruz Biotechnology, Inc.
  • Others

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Animal Biotechnology Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Animal Biotechnology Historical Market (2017-2021) 
    8.3    Global Animal Biotechnology Market Forecast (2022-2027)
    8.4    Global Animal Biotechnology Market by Product Type
        8.4.1    Reproductive and Genetic Products
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Diagnostic Tests
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Drugs
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Vaccines
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
    8.5    Global Animal Biotechnology Market by Application
        8.5.1    Food Safety and Drug Development
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Development of Animal Pharmaceuticals
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Others
    8.6    Global Animal Biotechnology Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Bayer AG
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Boehringer Ingelheim International GmbH
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Zoetis Inc
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Virbac Group
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Santa Cruz Biotechnology, Inc.
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments


List Key of Figures and Tables

1.    Global Animal Biotechnology Market: Key Industry Highlights, 2017 and 2021
2.    Global Animal Biotechnology Historical Market: Breakup by Product Type (USD Billion), 2017-2021
3.    Global Animal Biotechnology Market Forecast: Breakup by Product Type (USD Billion), 2022-2027
4.    Global Animal Biotechnology Historical Market: Breakup by Application (USD Billion), 2017-2021
5.    Global Animal Biotechnology Market Forecast: Breakup by Application (USD Billion), 2022-2027
6.    Global Animal Biotechnology Historical Market: Breakup by Region (USD Billion), 2017-2021
7.    Global Animal Biotechnology Market Forecast: Breakup by Region (USD Billion), 2022-2027
8.    North America Animal Biotechnology Historical Market: Breakup by Country (USD Billion), 2017-2021
9.    North America Animal Biotechnology Market Forecast: Breakup by Country (USD Billion), 2022-2027
10.    Europe Animal Biotechnology Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    Europe Animal Biotechnology Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Asia Pacific Animal Biotechnology Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Asia Pacific Animal Biotechnology Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Latin America Animal Biotechnology Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Latin America Animal Biotechnology Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Middle East and Africa Animal Biotechnology Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Middle East and Africa Animal Biotechnology Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Global Animal Biotechnology Market Structure

Key Questions Answered in the Report

In 2021, the global market for animal biotechnology attained a value of nearly USD 24.24 billion.

The market is projected to grow at a CAGR of 7.0% between 2022 and 2027.

The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 36.37 billion by 2027.

The growing population, which leads to the increased need for animal products, improving animal growth and disease resistance and technological advancements are major factors driving the industry.

Vaccine development to increase disease resistance and government initiatives to promote animal health are the key trends followed in the industry.

Applying biotechnology makes it possible to raise the productivity of animals and the nutrients in the product. This happens by improving the nutrition and feed utilised and better animal healthcare and welfare. In case of Genetical engineering, from increasing the productivity it can also improve resistance to diseases of animals.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the leading region in the market. 

The product types in the market of animal biotechnology include reproductive and genetic products, diagnostic tests, drugs, and vaccines.

The various applications in the market include food safety, drug development and the development of animal pharmaceuticals, among others.

Animal biotechnology has applications in various industries, some of the major industries include pharmaceutical, crop and agriculture, food and cattle farming.

Animal biotechnology provides multiple benefits for us and animals equally. The future potential of it is enhanced by the growing population, growing demand for nutritional food, increased disease resistance, and it can also be used to save endangered animal species.

There is plethora of technologies applied in animal biotechnology. Some of the most discussed and researched technologies are cloning, transgenics, in-vitro fertilisation, genome alteration, and embryo transfer, among others.

The major players in the industry are Bayer AG, Boehringer Ingelheim International GmbH, Zoetis Inc, Virbac Group, and Santa Cruz Biotechnology, Inc., among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER